Clinical Trial

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Name: Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis — clinical trial record (NCT06723080)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-12-05; most recent amendment 2026-07-23.

Status change: Not Yet Recruiting → Recruiting 2025-02-07

Trial Details

NCT Number	NCT06723080
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Moderate to Severe Atopic Dermatitis
Enrollment	480 participants
Start Date	2024-12-30
Primary Completion	2027-08-30 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-27